Anne Westermann
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 8
- Chronic Lymphocytic Leukemia Research 8
-
- Lymphoma Diagnosis and Treatment 5
- Co-authors
- Zachary S. Peacock (1 shared paper)Jacobus van der Velden (1 shared paper)Willem Hans Schreuder (1 shared paper)Jan de Lange (1 shared paper)Jim A. Reekers (1 shared paper)Christianne Lok (1 shared paper)Henk van den Berg (1 shared paper)Stephan Stilgenbauer (2 shared papers)
- Journals
- Blood (5 papers)Journal of Cranio-Maxillofacial Surgery (1 paper)Cancer (1 paper)The Lancet (1 paper)Gynecologic Oncology (1 paper)
- Partner nations
- GermanyNetherlandsAustria
In The Last Decade
Anne Westermann
11 papers receiving 2.1k citations
Anne Westermann's Hit Papers
Peers
Comparison fields: 5 of 53
- Genetics 1.9k
- Pathology and Forensic Medicine 1.3k
- Immunology 721
- Hematology 314
- Gastroenterology 72
Countries citing papers authored by Anne Westermann
This map shows the geographic impact of Anne Westermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Westermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Westermann more than expected).
Fields of papers citing papers by Anne Westermann
This network shows the impact of papers produced by Anne Westermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Westermann. The network helps show where Anne Westermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne Westermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial Hit paper breakdown → | 2010 | 1557 |
| 2 | 2009 | 274 | |
| 3 | 2008 | 111 | |
| 4 | 2009 | 75 | |
| 5 | 2013 | 58 | |
| 6 | 2016 | 29 | |
| 7 | 2005 | 24 | |
| 8 | 2018 | 16 | |
| 9 | 2011 | 14 | |
| 10 | 2009 | 5 | |
| 11 | 2014 | 4 |
About Anne Westermann
Anne Westermann is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Obstetrics and Gynecology and Public Health, Environmental and Occupational Health, having authored 11 papers that have together received 2.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (8 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Acute Lymphoblastic Leukemia research (2 papers), Pregnancy and preeclampsia studies (1 paper), Histiocytic Disorders and Treatments (1 paper), Ectopic Pregnancy Diagnosis and Management (1 paper) and Endometriosis Research and Treatment (1 paper). The work is most often cited by research in Genetics (1.9k citations), Pathology and Forensic Medicine (1.3k citations), Immunology (721 citations), Hematology (314 citations) and Gastroenterology (72 citations). Anne Westermann has collaborated with scholars based in Germany, Netherlands and Austria. Frequent co-authors include Zachary S. Peacock, Jacobus van der Velden, Willem Hans Schreuder, Jan de Lange, Jim A. Reekers, Christianne Lok, Henk van den Berg, Stephan Stilgenbauer, Georg Hopfinger and Anna‐Maria Fink. Their work appears in journals such as Blood, Journal of Cranio-Maxillofacial Surgery, Cancer, The Lancet and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.